Publications
Showing entries 101 - 120 out of 212
2018
El Abiead Y, Schwaiger-Haber M, Hermann G, Köllensperger G. Scrutinizing feature selection in untargeted metabolomics. In Yost RA, editor, Conference Proceedings for the 66th ASMS Conference. 2018
Frensemeier LM, Mayr J, Koellensperger G, Keppler BK, Kowol CR, Karst U. Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS). The Analyst. 2018 May 7;143(9):1997-2001. doi: 10.1039/c8an00258d
Mairinger T, Wegscheider W, Peña DA, Steiger MG, Koellensperger G, Zanghellini J et al. Comprehensive assessment of measurement uncertainty in 13C-based metabolic flux experiments. Analytical and Bioanalytical Chemistry. 2018 May 1;410(14):3337-3348. doi: 10.1007/s00216-018-1017-7
Theiner S, Grabarics M, Galvez L, Varbanov HP, Sommerfeld NS, Galanski MS et al. The impact of whole human blood on the kinetic inertness of platinum(IV) prodrugs - an HPLC-ICP-MS study. Dalton Transactions. 2018 Apr 21;47(15):5252-5258. doi: 10.1039/c7dt04537a
Rampler E, Schoeny H, Mitic BM, El Abiead Y, Schwaiger M, Koellensperger G. Simultaneous non-polar and polar lipid analysis by on-line combination of HILIC, RP and high resolution MS. The Analyst. 2018 Mar 7;143(5):1250-1258. doi: 10.1039/c7an01984j
Guijas C, Montenegro-Burke JR, Domingo-Almenara X, Palermo A, Warth B, Hermann G et al. METLIN: A Technology Platform for Identifying Knowns and Unknowns. Analytical Chemistry. 2018 Mar 6;90(5):3156-3164. doi: 10.1021/acs.analchem.7b04424
Klose MHM, Theiner S, Kornauth C, Meier-Menches SM, Heffeter P, Berger W et al. Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS. Metallomics: integrated biometal science. 2018 Mar 1;10(3):388-396. doi: 10.1039/c8mt00012c
Pelivan K, Frensemeier LM, Karst U, Koellensperger G, Heffeter P, Keppler BK et al. Comparison of metabolic pathways of different alpha-N-heterocyclic thiosemicarbazones. Analytical and Bioanalytical Chemistry. 2018 Mar;410(9):2343-2361. doi: 10.1007/s00216-018-0889-x
Rampler E, Schöny H, Chu DB, Hermann G, Schöberl A, Neumayer S et al. ICP-MS based quantification in "omics" applications. In Barnes R, editor, Book of Abstracts. 2018
Fischer L, Galvez L, Miro M, Köllensperger G, Hann S. Novel Developments and Applications of LC-ICP-MS in Bioaccessibility/Bioavailability Studies. In Barnes R, editor, Book of Abstracts. 2018
Heilos D, Röhrl C, Pirker C, Englinger B, Baier D, Mohr T et al. Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins. Oncotarget. 2018;9(39):25661-25680. doi: 10.18632/oncotarget.25432
2017
Fronik P, Mayr J, Heffeter P, Groza D, Schueffl H, Galvez L et al. Maleimide-bearing oxaliplatin(IV) complexes with outstanding antitumor activity in vivo. In Book of Abstracts. 2017
Theiner S, Van Malderen SJM, Van Acker T, Legin A, Keppler BK, Vanhaecke F et al. Fast High-Resolution Laser Ablation-Inductively Coupled Plasma Mass Spectrometry Imaging of the Distribution of Platinum-Based Anticancer Compounds in Multicellular Tumor Spheroids. Analytical Chemistry. 2017 Dec 5;89(23):12641-12645. doi: 10.1021/acs.analchem.7b02681
Schoenhacker-Alte B, Mohr T, Pirker C, Kryeziu K, Kuhn PS, Buck A et al. Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis. Cancer Letters. 2017 Sept 28;404:79-88. doi: 10.1016/j.canlet.2017.07.009
Holzlechner M, Theiner S, Van Malderen S, Vanhaecke F, Köllensperger G, Marchetti-Deschmann M. Multiple Modes & Sensors: positive/negative ion mode MALDI-TOF and LA-ICP MS imaging of tumor spheroids and mesothelioma samples. 2017. OurCon V – Mass Spectrometry Imaging Conference, Doorn, Netherlands.
Pelivan K, Frensemeier L, Karst U, Köllensperger G, Bielec B, Heffeter P et al.. Understanding the metabolism of the anticancer drug Triapine by electrochemical oxidation, in vitro and in vivo. 2017. Paper presented at 17. Österreichische Chemietage 2017, Salzburg, Austria.
Sommerfeld NS, Strohhofer D, Cseh K, Theiner S, Jakupec MA, Koellensperger G et al. Platinum(IV) Complexes Featuring Axial Michael Acceptor Ligands - Synthesis, Characterization, and Cytotoxicity. European Journal of Inorganic Chemistry. 2017 Sept 15;2017(34):4049-4054. doi: 10.1002/ejic.201700753
Pelivan K, Frensemeier L, Karst U, Koellensperger G, Bielec B, Hager S et al. Understanding the metabolism of the anticancer drug Triapine: electrochemical oxidation, microsomal incubation and in vivo analysis using LC-HRMS. The Analyst. 2017 Sept 7;142(17):3165-3176. doi: 10.1039/c7an00902j
Kowol C, Heffeter P, Mayr J, Groza D, Galvez L, Köllensperger G et al. Distinctly enhanced anticancer activity in vivo by albumin-targeted platinum(IV) prodrugs. In Book of Abstracts. 2017
Schueffl H, Mayr J, Groza D, Galvez L, Lahnsteiner M, Köllensperger G et al. Impact of linker modification on the in vitro and in vivo anticancer activity of novel albumin-targeting Platinum (IV) drugs. In Book of Abstracts. 2017
Showing entries 101 - 120 out of 212